Intrinsic Value

Syndax Pharmaceuticals, Inc. (SNDX)


+0.41 (+1.72%)

Enterprise Value -9,048,427,940,093.33
Net Debt -221.97
Equity Value -9,048,427,939,871.37
Shares Outstanding 51.96
Equity Value Per Share -174,134,410,085.45

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt